M Taeschler

692 total citations
41 papers, 485 citations indexed

About

M Taeschler is a scholar working on Organic Chemistry, Molecular Biology and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, M Taeschler has authored 41 papers receiving a total of 485 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Organic Chemistry, 10 papers in Molecular Biology and 5 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in M Taeschler's work include Phenothiazines and Benzothiazines Synthesis and Activities (6 papers), Psychedelics and Drug Studies (4 papers) and Coordination Chemistry and Organometallics (4 papers). M Taeschler is often cited by papers focused on Phenothiazines and Benzothiazines Synthesis and Activities (6 papers), Psychedelics and Drug Studies (4 papers) and Coordination Chemistry and Organometallics (4 papers). M Taeschler collaborates with scholars based in Japan, United States and Switzerland. M Taeschler's co-authors include Richard J. Bing, A Cerletti, A. Siegel, Fiamma Balboni, Hans Weidmann, Michael H. Klapper, H. Konzett, E Rothlin, Wolfgang Schalch and D. Loew and has published in prestigious journals such as Nature, Circulation and Annals of Internal Medicine.

In The Last Decade

M Taeschler

39 papers receiving 391 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
M Taeschler Japan 9 171 93 69 61 58 41 485
I. R. Innes Canada 15 260 1.5× 217 2.3× 171 2.5× 169 2.8× 32 0.6× 49 742
Morselli Pl Italy 16 72 0.4× 81 0.9× 125 1.8× 78 1.3× 14 0.2× 45 682
Joop C. van Oene Netherlands 12 103 0.6× 226 2.4× 186 2.7× 72 1.2× 23 0.4× 24 652
Joseph V. Levy United States 16 221 1.3× 220 2.4× 116 1.7× 216 3.5× 29 0.5× 64 881
G. Kuschinsky Germany 15 135 0.8× 275 3.0× 80 1.2× 77 1.3× 18 0.3× 99 751
H Hochrein Germany 13 376 2.2× 131 1.4× 18 0.3× 58 1.0× 83 1.4× 131 714
G. Raberger Austria 15 385 2.3× 141 1.5× 61 0.9× 162 2.7× 84 1.4× 122 732
Aado Vendsalu Sweden 6 98 0.6× 69 0.7× 51 0.7× 91 1.5× 10 0.2× 9 422
Joseph A. Josephs United States 7 90 0.5× 71 0.8× 75 1.1× 75 1.2× 16 0.3× 10 364
E. F. Woods United States 14 305 1.8× 108 1.2× 58 0.8× 57 0.9× 59 1.0× 37 634

Countries citing papers authored by M Taeschler

Since Specialization
Citations

This map shows the geographic impact of M Taeschler's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M Taeschler with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M Taeschler more than expected).

Fields of papers citing papers by M Taeschler

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M Taeschler. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M Taeschler. The network helps show where M Taeschler may publish in the future.

Co-authorship network of co-authors of M Taeschler

This figure shows the co-authorship network connecting the top 25 collaborators of M Taeschler. A scholar is included among the top collaborators of M Taeschler based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M Taeschler. M Taeschler is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Taeschler, M, et al.. (1998). [On the significance of various pharmacodynamic properties of phenothiazine derivatives in relation to their clinical efficacy].. PubMed. 139. 85–104.
2.
Loew, D & M Taeschler. (1968). Profiles of Activity of Psychotropic Drugs A Way to Predict Therapeutic Effects. International Pharmacopsychiatry. 1(1). 1–20. 1 indexed citations
3.
Loew, D., et al.. (1967). [Pharmacological, pharmacokinetic and toxicological research on mesoridazine (NC 123)].. PubMed. 106(5). 332–71. 1 indexed citations
4.
Kühn, Ralf, et al.. (1966). Pharmakologische und klinische Eigenschaften eines neuen Butyrophenon-Derivates (FR 33). Psychopharmacology. 9(4). 351–362. 3 indexed citations
5.
Loew, D. & M Taeschler. (1966). Die Wirkung tricyclischer Antidepressiva auf die 5-Hydroxytryptophan-Hyperthermie des Kaninchens. Naunyn-Schmiedeberg s Archives of Pharmacology. 252(5). 399–406. 7 indexed citations
6.
Loew, D. & M Taeschler. (1965). Der Einflu� von tricyclischen Antidepressiva und Thioridazin auf das 5-Hydroxytryptophan (5-HTP)-Fieber des Kaninchens. Naunyn-Schmiedeberg s Archives of Pharmacology. 251(2). 139–139. 2 indexed citations
7.
Loew, D. & M Taeschler. (1964). [ON THE ANALGESIC EFFECT OF RS 86, A CHOLINOMIMETIC WITH CENTRAL ACTION].. PubMed. 22. C80–2. 2 indexed citations
8.
Schalch, Wolfgang, et al.. (1963). [THE NEW SALURETIC BRINALDIX (DT-327)].. PubMed. 93. 1232–7. 12 indexed citations
9.
Taeschler, M, Hans Weidmann, & A Cerletti. (1962). [On the pharmacology of Ponalid, a new central anticholinergic].. PubMed. 92. 1542–5. 8 indexed citations
10.
Taeschler, M & A Cerletti. (1960). [On the pharmacology of psycho-active substances].. PubMed. 102. 1000–5. 2 indexed citations
11.
Taeschler, M & A Cerletti. (1958). On the pharmacology of Thioridazin, Melleril.. PubMed. 88(48). 1216–20. 3 indexed citations
12.
Taeschler, M, et al.. (1957). [Central effects of lysergic acid diethylamide; studies on the localization of lysergic acid diethylamide effects].. PubMed. 15(1). 1–7. 4 indexed citations
13.
Taeschler, M & A Cerletti. (1957). SOME OBSERVATIONS ON THE INTERACTION OF RESERPINE AND LSD. Journal of Pharmacology and Experimental Therapeutics. 120(2). 179–183. 6 indexed citations
14.
Cerletti, A, H. Konzett, & M Taeschler. (1955). Canescin, ein mit Reserpin wirkungsgleiches Alkaloid ausRauwolfia canescens. Cellular and Molecular Life Sciences. 11(3). 98–99. 2 indexed citations
15.
Rothlin, E, M Taeschler, H. Konzett, & A Cerletti. (1954). Über einige pharmakologische Untersuchungen synthetischer Alkoxy-tropinderivate. Cellular and Molecular Life Sciences. 10(3). 142–145. 7 indexed citations
16.
Bing, Richard J., et al.. (1953). Metabolic studies on the human heart in vivo. The American Journal of Medicine. 14(6). 746–746. 29 indexed citations
17.
Cerletti, A, et al.. (1953). [Various behavior of the right and left heart to induced and spontaneous insufficiency of the heart-lung preparation].. PubMed. 11(2). C13–4. 3 indexed citations
18.
Taeschler, M, A Cerletti, & E Rothlin. (1952). [Effects of hydergin on cerebral circulation].. PubMed. 10(2). 120–37. 8 indexed citations
19.
Bing, Renjie, et al.. (1952). CONGENITAL HEART DISEASE: A CLINICAL AND PHYSIOLOGIC CORRELATION. Annals of Internal Medicine. 37(4). 664–676. 1 indexed citations
20.
Bing, Richard J. & M Taeschler. (1952). Cardiac Failure and Cardiac Muscle. Cardiology. 21(4-5). 283–289. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026